Paul Whitney
Directeur Général chez Parallel Private Equity LLP
Postes actifs de Paul Whitney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Parallel Private Equity LLP
 Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | Directeur Général | 01/01/1997 | - |
| Président | 01/01/1997 | - | |
| Directeur en chef des Investissements | 01/01/1997 | - |
Historique de carrière de Paul Whitney
Anciens postes connus de Paul Whitney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Président | 08/11/2006 | 18/07/2007 |
| NatWest Equity Partners Ltd. | Président | 01/01/1993 | - |
3i Plc
 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/1983 | 01/01/1983 |
| Bridgepoint Capital (GP) Ltd. | Président | - | - |
CIN Management Ltd.
 CIN Management Ltd. Investment ManagersFinance Part of The Goldman Sachs Group, Inc., CIN Management Ltd. is a pension fund manager. The company is based in London, UK. CIN Management was acquired by Goldman Sachs Ltd. from British Coal Corp. on July 22, 1996 for $65 million. | Directeur Général | - | - |
Formation de Paul Whitney
| University of Aston | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Statistiques
Internationale
| Royaume-Uni | 9 |
Opérationnelle
| Chairman | 4 |
| Chief Executive Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Finance | 5 |
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | Finance |
| NatWest Equity Partners Ltd. | Finance |
3i Plc
3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Finance |
CIN Management Ltd.
CIN Management Ltd. Investment ManagersFinance Part of The Goldman Sachs Group, Inc., CIN Management Ltd. is a pension fund manager. The company is based in London, UK. CIN Management was acquired by Goldman Sachs Ltd. from British Coal Corp. on July 22, 1996 for $65 million. | Finance |
| Bridgepoint Capital (GP) Ltd. |
- Bourse
- Insiders
- Paul Whitney
- Expérience
